i‑80 Gold Corp. closed an upsized offering of 3.75% unsecured convertible senior notes due 2031, raising $287.5 million. The proceeds include the original $250 million offering and the full exercise of a $37.5 million option granted to initial purchasers.
The new capital will fund the company’s five gold projects, refurbish the Lone Tree processing plant, support resource expansion and infill drilling, and provide general corporate and working‑capital needs. The financing is a key step toward the company’s mid‑tier production strategy, enabling the Lone Tree autoclave refurbishment that is expected to improve processing efficiency and margins.
Management highlighted the strategic importance of the financing. CEO Richard Young said, “We have made significant progress advancing our development plan and recapitalizing the company’s balance sheet toward our goal of creating a mid‑tier gold producer.” COO W. Chawrun added, “Operations and development work progressed well over the quarter with mining at Granite Creek and advancement rates at Archimedes performing better than planned.” CFO Ryan Snow noted that gold sales and revenue for the year ended December 31 2025 were higher than the prior year, underscoring the company’s growth trajectory.
The capital raise comes at a time when i‑80 Gold has faced substantial net losses and a limited cash runway, but the new liquidity will help the company reduce debt, fund critical capital projects, and position itself for future equity or debt financing. The autoclave refurbishment at Lone Tree is a cornerstone of the company’s plan to increase gold recovery from refractory ore, potentially raising margins from the current 55‑60% toll milling rates to an estimated 92% in‑house processing.
The financing also supports the ramp‑up of the Granite Creek project, which is a key component of the company’s phased development plan to increase annual gold production from under 50,000 ounces to over 600,000 ounces by the early 2030s. By strengthening its balance sheet, i‑80 Gold aims to secure additional financing and accelerate its transition to a mid‑tier producer.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.